SuperworthInnovAge revenue INNV
Sales by quarter and over the last twelve months, from 2020.
- Last 12 months, to Jun 30, 2026
- $989.7M
- Latest quarter, Q4 FY26
- $262M
- +18% on a year earlier
- Fiscal year 2026
- $989.7M
- +16% on the year before
InnovAge's revenue was $989.7M over the twelve months to Jun 30, 2026, up 16% on a year earlier.
In its latest quarter, Q4 FY26, it was $262M, up 18% on the same quarter a year before.
Over the five fiscal years to FY2026 it grew 9% a year on average.
Revenue over time
Fiscal year by fiscal year
| Fiscal year | Revenue | Change |
|---|---|---|
| FY2026 | $989.7M | +16% |
| FY2025 | $853.7M | +12% |
| FY2024 | $763.9M | +11% |
| FY2023 | $688.1M | −2% |
| FY2022 | $698.6M | +10% |
| FY2021 | $637.8M | n/a |
| FY2020 | n/a | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | Revenue | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q4 FY26 | $262M | +18% | $989.7M | |
| Q3 FY26 | $251.9M | +15% | $949.2M | |
| Q2 FY26 | $239.7M | +15% | $915.4M | |
| Q1 FY26 | $236.1M | +15% | $884.7M | |
| Q4 FY25 | $221.4M | +11% | $853.7M | |
| Q3 FY25 | $218.1M | +13% | $831.7M | |
| Q2 FY25 | $209M | +11% | $806.6M | |
| Q1 FY25 | $205.1M | +12% | $786.5M | |
| Q4 FY24 | $199.4M | +13% | $763.9M | |
| Q3 FY24 | $193.1M | +12% | $741.3M | |
| Q2 FY24 | $188.9M | +13% | $720.8M | |
| Q1 FY24 | $182.5M | +7% | $699.4M |
Against its peers
Companies in Medical - Care Facilities nearest InnovAge's size, closest first, today.
| Company | Revenue, 12 months | Growth |
|---|---|---|
| INNVInnovAge | $989.7M | +16% a year |
| USPHU S Physical Therapy | $812.2M | +11% a year |
| PNTGPennant | $1.1B | +38% a year |
| OMDAOmada Health | $309.8M | +48% a year |
| ARDTArdent Health | $6.4B | +3% a year |
| HCSGHealthcare Services | $1.9B | +4% a year |
| PGNYProgyny | $1.3B | +6% a year |
| ADUSAddus HomeCare | $1.5B | +16% a year |
| MDPediatrix Medical | $2B | +1% a year |
| PRVAPrivia Health | $2.4B | +24% a year |
| AVAHAveanna Healthcare | $2.6B | +20% a year |
| Peer median | $1.7B |
Where InnovAge ranks
What the revenue tells you
Total sales in the period. On the company page, quarterly bars or the trailing twelve months (TTM), which smooths seasonality.
Growing revenue with shrinking margins is a warning, not a win.
More on InnovAge
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.